Ivanova, E.,
Asadullina, D.,
Rakhimov, R.,
Izmailov, A.,
Izmailov, Al.,
Gilyazova, G.,
Galimov, Sh.,
Pavlov, V.,
Khusnutdinova, E.,
Gilyazova, I. (2022) cancellation and
therapy failure. Modern studies demonstrate evidence that exosomes are of great importance
Kazantseva, A.V.,
Davydova, Yu. D.,
Enikeeva, R.F.,
Mustafin, R.N.,
Lobaskova, M.M.,
Malykh, S.B.,
Khusnutdinova, E.K. (2022) component (TERC rs1317082), and the CST
complex encoding protein (OBFC1 rs2487999) gene polymorphisms
Dobrodeeva, V.S.,
Shnayder, N.A.,
Novitsky, M.A.,
Asadullin, A.R.,
Vaiman, E.E.,
Petrova, M.M.,
Limankin, O.V.,
Neznanov, N.G.,
Garganeeva, N.P.,
Nasyrova, R.F. (2022) weight of more than 6% since the start of APs
therapy. Group 2 comprised 74 patients with SSDs taking APs
be used for diagnosis and prognosis, including the response of a particular patient to
therapy the sensitivity of glioblastoma to current
therapies. © 2022 The Authors
. Glioblastoma (GBM), a grade IV brain tumor, is known for its heterogeneity and resistance to
therapy. Modern